TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from OptiBiotix Health ( (GB:OPTI) ) is now available.
OptiBiotix Health plc has signed a distribution agreement with a prominent weight management company to provide SlimBiome® and WellBiome® products under the distributor’s branding. This partnership aims to leverage the growing interest in non-drug alternatives for weight management, positioning OptiBiotix to integrate its science-backed ingredients into established brands. The agreement is expected to enhance OptiBiotix’s market presence and open new opportunities in the European market.
More about OptiBiotix Health
OptiBiotix Health plc, established in March 2012, is a life sciences company focused on developing compounds that modify the human microbiome to prevent and manage diseases and promote wellness. The company collaborates with international food and healthcare supplement companies to incorporate its microbiome modulators into various food products and drinks. OptiBiotix’s primary areas of focus include obesity, cardiovascular health, and diabetes.
Average Trading Volume: 346,232
Technical Sentiment Signal: Sell
Current Market Cap: £13.43M
Find detailed analytics on OPTI stock on TipRanks’ Stock Analysis page.